Topics
Gliomas | Treatment | Clinical trials | Vorasidenib
Home > Publications > Topics > Gliomas > Treatment > Clinical trials > Vorasidenib
de la Fuente MI, Touat M, van den Bent MJ, Preusser M, Peters KB,
Young RJ, Huang RY, Ellingson BM, Capper D, Phillips JJ, Halasz
LM, Shih HA, Rudà R, Lim-Fat MJ, Blumenthal DT, Weller M,
Arakawa Y, Whittle JR, Ducray F, Reardon DA, Bi WL, Minniti G,
Rahman R, Hervey-Jumper S, Chang SM, Wen PY.
The
role of vorasidenib in the treatment of isocitrate
dehydrogenase-mutant glioma.
Neuro
Oncol. 2024 Dec 25:noae259. doi:
10.1093/neuonc/noae259. PMID:
39723472. Review: Interventional study. ˍ